Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI

  • 329 Accesses

  • 3 Citations

Abstract

Purpose

Newer high-performance time-of-flight (TOF) positron emission tomography (PET) systems have the capability to preserve diagnostic image quality with low count density, while maintaining a high raw photon detection sensitivity that would allow for a reduction in injected dose or rapid data acquisition. To assess this, we performed quantitative and visual assessments of the PET images acquired using a highly sensitive (23.3 cps/kBq) large field of view (25-cm axial) silicon photomultiplier (SiPM)-based TOF PET (400-ps timing resolution) integrated with 3 T-MRI in comparison to PET images acquired on non-TOF PET/x-ray computed tomography (CT) systems.

Procedures

Whole-body 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET/CT was acquired for 15 patients followed by whole body PET/magnetic resonance imaging (MRI) with an average injected dose of 325 ± 84 MBq. The PET list mode data from PET/MRI were reconstructed using full datasets (4 min/bed) and reduced datasets (2, 1, 0.5, and 0.25 min/bed). Qualitative assessment between PET/CT and PET/MR images were made. A Likert-type scale between 1 and 5, 1 for non-diagnostic, 3 equivalent to PET/CT, and 5 superior quality, was used. Maximum and mean standardized uptake values (SUVmax and SUVmean) of normal tissues and lesions detected were measured and compared.

Results

Mean visual assessment scores were 3.54 ± 0.32, 3.62 ± 0.38, and 3.69 ± 0.35 for the brain and 3.05 ± 0.49, 3.71 ± 0.45, and 4.14 ± 0.44 for the whole-body maximum intensity projections (MIPs) for 1, 2, and 4 min/bed PET/MR images, respectively. The SUVmean values for normal tissues were lower and statistically significant for images acquired at 4, 2, 1, 0.5, and 0.25 min/bed on the PET/MR, with values of – 18 ± 28 % (p < 0.001), − 16 ± 29 % (p = 0.001), − 16 ± 31 % (p = 0.002), − 14 ± 35 % (p < 0.001), and − 13 ± 34 % (p = 0.002), respectively. SUVmax and SUVpeak values of all lesions were higher and statistically significant (p < 0.05) for 4, 2, 1, 0.50, and 0.25 min/bed PET/MR datasets.

Conclusion

High-sensitivity TOF PET showed comparable but still better visual image quality even at a much reduced activity in comparison to lower-sensitivity non-TOF PET. Our data translates to a seven times reduction in either injection dose for the same time or total scan time for the same injected dose. This “ultra-sensitivity” PET system provides a path to clinically acceptable extremely low-dose FDG PET studies (e.g., sub 1 mCi injection or sub-mSv effective dose) or PET studies as short as 1 min/bed (e.g., 6 min of total scan time) to cover whole body without compromising diagnostic performance.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Vandenberghe S, Mikhaylova E, D'Hoe E, Mollet P, Karp JS (2016) Recent developments in time-of-flight PET. EJNMMI Phys 3(1):3. https://doi.org/10.1186/s40658-016-0138-3

  2. 2.

    Karp JS, Surti S, Daube-Witherspoon ME, Muehllehner G (2008) Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med 49(3):462–470. https://doi.org/10.2967/jnumed.107.044834

  3. 3.

    Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS (2007) Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 48(3):471–480

  4. 4.

    Miller M, Zhang J, Binzel K et al (2015) Characterization of the Vereos digital photon counting PET system. J Nucl Med 56:434

  5. 5.

    Schmall JP, Wiener RI, Surti S, Ferri A, Gola A, Tarolli A, Piemonte C, Karp JS (2014) Timing and energy resolution of new near-UV SiPMs coupled to LaBr3:Ce for TOF-PET. IEEE Trans Nucl Sci 61(5):2426–2432. https://doi.org/10.1109/TNS.2014.2346579

  6. 6.

    David S, Jakob W, Peter Michael D et al (2015) PET performance and MRI compatibility evaluation of a digital, ToF-capable PET/MRI insert equipped with clinical scintillators. Phys Med Biol 60:7045

  7. 7.

    Martins P, Blanco A, Crespo P, Marques MFF, Marques RF, Gordo PM, Kajetanowicz M, Korcyl G, Lopes L, Michel J, Palka M, Traxler M, Fonte P (2014) Towards very high resolution RPC-PET for small animals. J Instrum 9(10):C10012. https://doi.org/10.1088/1748-0221/9/10/C10012

  8. 8.

    Beiderwellen KJ, Poeppel TD, Hartung-Knemeyer V, Buchbender C, Kuehl H, Bockisch A, Lauenstein TC (2013) Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results. Investig Radiol 48(5):273–279. https://doi.org/10.1097/RLI.0b013e3182871a7f

  9. 9.

    Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW (2009) Impact of time-of-flight on PET tumor detection. J Nucl Med 50(8):1315–1323. https://doi.org/10.2967/jnumed.109.063016

  10. 10.

    Taniguchi T, Akamatsu G, Kasahara Y, Mitsumoto K, Baba S, Tsutsui Y, Himuro K, Mikasa S, Kidera D, Sasaki M (2015) Improvement in PET/CT image quality in overweight patients with PSF and TOF. Ann Nucl Med 29(1):71–77. https://doi.org/10.1007/s12149-014-0912-z

  11. 11.

    Karlberg AM, Saether O, Eikenes L, Goa PE (2016) Quantitative comparison of PET performance-Siemens biograph mCT and mMR. EJNMMI Phys 3(1):5. https://doi.org/10.1186/s40658-016-0142-7

  12. 12.

    Lois C, Jakoby BW, Long MJ, Hubner KF, Barker DW, Casey ME, Conti M, Panin VY, Kadrmas DJ, Townsend DW (2010) An assessment of the impact of incorporating time-of-flight information into clinical PET/CT imaging. J Nucl Med 51(2):237–245. https://doi.org/10.2967/jnumed.109.068098

  13. 13.

    Zeimpekis KG, Barbosa F, Hüllner M, ter Voert E, Davison H, Veit-Haibach P, Delso G (2015) Clinical evaluation of PET image quality as a function of acquisition time in a new TOF-PET/MRI compared to TOF-PET/CT—initial results. Mol Imaging Biol 17(5):735–744. https://doi.org/10.1007/s11307-015-0845-5

  14. 14.

    Armstrong IS, James JM, Williams HA, Kelly MD, Matthews JC (2015) The assessment of time-of-flight on image quality and quantification with reduced administered activity and scan times in 18F-FDG PET. Nucl Med Commun 36(7):728–737. https://doi.org/10.1097/MNM.0000000000000305

  15. 15.

    Kadrmas DJ, Oktay MB, Casey ME, Hamill JJ (2012) Effect of scan time on oncologic lesion detection in whole-body PET. IEEE Trans Nucl Sci 59(5):1940–1947. https://doi.org/10.1109/TNS.2012.2197414

  16. 16.

    Hausmann D, Bittencourt LK, Attenberger UI, Sertdemir M, Weidner A, Büsing KA, Brade J, Wenz F, Schoenberg SO, Dinter DJ (2014) Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence. Clin Nucl Med 39(3):e197–e201. https://doi.org/10.1097/RLU.0b013e3182a23d37

  17. 17.

    Grant AM, Deller TW, Khalighi MM, Maramraju SH, Delso G, Levin CS (2016) NEMA NU 2-2012 performance studies for the SiPM-based ToF-PET component of the GE SIGNA PET/MR system. Med Phys 43(5):2334–2343. https://doi.org/10.1118/1.4945416

  18. 18.

    Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MG, Zubal G, Kachelriess M, Cronin V, Holbrook S (2006) Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 47(5):885–895

  19. 19.

    Jones SC, Alavi A, Christman D, Montanez I, Wolf AP, Reivich M (1982) The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med 23(7):613–617

  20. 20.

    Kinahan PE, Fletcher JW (2010) PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. Semin Ultrasound CT MR 31(6):496–505. https://doi.org/10.1053/j.sult.2010.10.001

  21. 21.

    Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR (2013) Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol 15(3):345–352. https://doi.org/10.1007/s11307-012-0600-0

  22. 22.

    Cheng G, Torigian DA, Zhuang H, Alavi A (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 40(5):779–787. https://doi.org/10.1007/s00259-013-2343-9

  23. 23.

    Oldan JD, Turkington TG, Choudhury K, Chin BB (2015) Quantitative differences in [(18)F] NaF PET/CT: TOF versus non-TOF measurements. Am J Nucl Med Mol Imaging 5(5):504–514

  24. 24.

    Hamada K, Tomita Y, Ueda T, Enomoto K, Kakunaga S, Myoui A, Higuchi I, Yoshikawa H, Hatazawa J (2006) Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors. Ann Nucl Med 20(10):671–675

  25. 25.

    Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G (2015) Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality. Clin Nucl Med 40(1):1–8. https://doi.org/10.1097/RLU.0000000000000611

  26. 26.

    Koopman D, van Dalen JA, Lagerweij MC, Arkies H, de Boer J, Oostdijk AH, Slump CH, Jager PL (2015) Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions. J Nucl Med Technol 43(1):21–27. https://doi.org/10.2967/jnmt.114.147215

  27. 27.

    Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1):122S–150S. https://doi.org/10.2967/jnumed.108.057307

  28. 28.

    Velasquez LM, Boellaard R, Kollia G, Hayes W, Hoekstra OS, Lammertsma AA, Galbraith SM (2009) Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. J Nucl Med 50(10):1646–1654. https://doi.org/10.2967/jnumed.109.063347

  29. 29.

    Budinger TF (1983) Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med 24(1):73–78

  30. 30.

    Teras M, Tolvanen T, Johansson JJ, Williams JJ, Knuuti J (2007) Performance of the new generation of whole-body PET/CT scanners: discovery STE and discovery VCT. Eur J Nucl Med Mol Imaging 34(10):1683–1692. https://doi.org/10.1007/s00259-007-0493-3

  31. 31.

    Brambilla M, Secco C, Dominietto M, Matheoud R, Sacchetti G, Inglese E (2005) Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard. J Nucl Med 46(12):2083–2091

Download references

Funding

This project was supported in part by grant form GE Healthcare.

Author information

Correspondence to Emma Bahroos.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Behr, S.C., Bahroos, E., Hawkins, R.A. et al. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI. Mol Imaging Biol 20, 492–500 (2018). https://doi.org/10.1007/s11307-017-1145-z

Download citation

Key words

  • PET
  • PET/MRI
  • PET/CT
  • TOF
  • Sub-mSv
  • High-sensitivity
  • Timing resolution
  • Ultrafast